Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 149.41M | 146.37M | 128.18M | 138.16M | 96.12M | 71.96M | 56.57M | 57.57M | 63.29M | 38.78M | 65.98M | 36.55M | 62.73M | 107.02M | 24.19M | 27.3M | 21.58M |
Cost of Revenue | 2.8M | 7.45M | 1.93M | 11.21M | 8M | 1.79M | 4.55M | 2.32M | 3.17M | 4.85M | 3M | 4.89M | 5.08M | 7.55M | 3.79M | 6.49M | 102K |
Gross Profit | 146.61M | 138.92M | 126.25M | 126.95M | 88.11M | 70.17M | 52.01M | 55.25M | 60.11M | 33.93M | 62.98M | 31.66M | 57.65M | 99.47M | 20.4M | 20.8M | 21.47M |
Operating Income | -41.09M | -41.2M | -48.97M | -43.05M | -78.82M | -105.11M | -128.98M | -127.98M | -135.38M | -156.81M | -124.28M | -157.64M | -105.8M | -316.05M | -117.1M | -108.51M | -100.24M |
Interest Income | n/a | 10.39M | 11.15M | 9.94M | 9.18M | 9.83M | 9.33M | 7.75M | 5.9M | n/a | 2.95M | 433K | 442K | 1.65M | n/a | 633K | 738K |
Pretax Income | 1.28M | -49.28M | -56M | -49.89M | 89.32M | -110.86M | -133.52M | -132.6M | -129.04M | -157.6M | -132.28M | -156.58M | -105.81M | -316.05M | -117.07M | -108.25M | -99.71M |
Net Income | 496K | -49.96M | -56.28M | -49.99M | 89.14M | -110.92M | -133.71M | -132.79M | -129.56M | -158.64M | -133.16M | -159.71M | -106M | -318.69M | -117.24M | -108.44M | -99.71M |
Selling & General & Admin | 95.81M | 96.45M | 89.93M | 89.34M | 83.56M | 79.27M | 70.74M | 71.93M | 70.95M | 64.02M | 57.61M | 58.69M | 57.06M | 54.2M | 49.81M | 49.29M | 42M |
Research & Development | 91.89M | 83.67M | 85.3M | 80.65M | 83.38M | 96.01M | 110.25M | 110.06M | 112.07M | 117.84M | 127.98M | 128.47M | 103.13M | 356.88M | 84.42M | 80.03M | 79.71M |
Other Expenses | n/a | n/a | n/a | -1K | 376K | -577K | -728K | n/a | 1.3M | 1.87M | 1.67M | 2.15M | 3.27M | -381K | -522K | -373K | -214K |
Operating Expenses | 187.7M | 180.12M | 175.23M | 169.99M | 166.94M | 175.28M | 180.99M | 183.23M | 184.32M | 183.73M | 187.25M | 189.3M | 163.46M | 415.61M | 137.49M | 129.31M | 121.71M |
Interest Expense | -8.13M | 18.17M | 18.77M | 16.8M | 15.07M | 15M | 13.14M | 11.74M | 11.72M | 24.29M | 11.35M | 6K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 30.23M | 26.74M | 22.71M | 16.93M | 16.9M | 13.07M | 18.72M | 10.05M | 18.1M | 7.72M | n/a | n/a | 13.5M | n/a | n/a | n/a |
Cost & Expenses | 190.5M | 187.57M | 177.16M | 181.2M | 174.94M | 177.07M | 185.55M | 185.55M | 187.49M | 188.58M | 190.25M | 194.19M | 168.53M | 423.16M | 141.28M | 135.81M | 121.81M |
Income Tax Expense | 789K | 672K | 273K | 102K | 180K | 61K | 197K | 190K | 520K | 1.04M | 886K | 3.13M | 184K | 2.63M | 175K | 193K | -738K |
Shares Outstanding (Basic) | 63.6M | 63.6M | 63.38M | 62.85M | 61.58M | 60.89M | 60.69M | 60.52M | 60.13M | 59.87M | 59.71M | 59.62M | 59.31M | 58.98M | 58.62M | 58.41M | 58.02M |
Shares Outstanding (Diluted) | 63.6M | 63.6M | 63.38M | 62.85M | 63.8M | 60.89M | 60.69M | 60.52M | 60.13M | 59.87M | 59.76M | 59.62M | 59.31M | 58.98M | 58.65M | 58.41M | 58.02M |
EPS (Basic) | 0.01 | -0.79 | -0.89 | -0.8 | 1.45 | -1.82 | -2.2 | -2.19 | -2.15 | -2.65 | -2.23 | -2.68 | -1.79 | -5.4 | -2 | -1.86 | -1.72 |
EPS (Diluted) | 0.01 | -0.79 | -0.89 | -0.8 | 1.40 | -1.82 | -2.2 | -2.19 | -2.15 | -2.65 | -2.23 | -2.68 | -1.79 | -5.4 | -2 | -1.86 | -1.72 |
EBITDA | -41.09M | -27.11M | -33.37M | -29.48M | -74.01M | -103.58M | -115.2M | -115.03M | -111.44M | -139.19M | -120.16M | -155.1M | -102.15M | -312.75M | -113.86M | -106.92M | -98.63M |
EBIT | -6.84M | -31.12M | -37.24M | -33.09M | 104.39M | -123.46M | -120.38M | -120.86M | -117.32M | -147.93M | -123.88M | -156.57M | -105.81M | -311.6M | -117.07M | -108.51M | -100.24M |
Depreciation & Amortization | -34.24M | 4M | 3.86M | 3.62M | 4.81M | 1.53M | 5.17M | 5.83M | 5.89M | 9.17M | 3.73M | 3.54M | 3.67M | 3.3M | 3.21M | 3.14M | 3.13M |